Very early researchStudy completedNCT03387553
What this trial is testing
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer
Who this might be right for
Breast CancerBreast Cancer FemaleBreast Cancer, Male+5 more
H. Lee Moffitt Cancer Center and Research Institute 31